U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07000539) titled 'Indocyanine Green Fluorescence Angiography (ICG-FA) in Revisional Bariatric Surgery' on May 24.
Brief Summary: This study will compare different doses of a green fluorescent product that is administered during weight loss surgery in order to observe where blood vessels are located. There is uncertainty around the optimal dose of this product for patients with obesity, so this study will aim to study if the dose in the minimal range recommended by international guidelines is sufficient for most patients or if higher doses are needed with increasing body mass index.
Study Start Date: May 06
Study Type: INTERVENTIONAL
Condition:
Obe...